摘要
随着国内金融市场发展壮大,许多境外中概股回归到了国内市场。企业重回国内上市必须满足诸多条件,其中境外股权架构如何拆除并转移回国内就是回归核心问题之一。本文将以红筹架构公司药明康德的成功回归为案例,研究其回归方式,并分析该企业在架构拆除与私有化方法的创新与优势之处,以期为回归企业提供启示和思路。
With the development of the domestic financial market,many overseas Chinese stocks have returned to the domestic market.Many conditions must be met for an enterprise to return to the domestic market,and how to dismantle the overseas equity structure and transfer it back to China is one of the core issues.This article will take the successful return of the red-chip architecture company WuXi PharmaTech as a case to study its regression method and analyze the innovation and advantages of the company in the framework of dismantling and privatization methods,in order to provide inspiration and ideas for returning companies.
作者
陈思翰
CHEN Si-han(East China University of Science and Technology,Nanchang 330000,China)
出处
《价值工程》
2020年第13期107-108,共2页
Value Engineering
关键词
中概股回归
红筹架构
药明康德
Chinese stocks return
red chip structure
WuXi PharmaTech